Open original FDA record ↗Recall record
- FDA identifier
- Z-1397-2011
- Company in FDA record
- Abbott Molecular
- FDA classification date
- Feb 23, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Internal testing identified the potential of under filled and over filled enzyme reagent vials which may result in obtaining less than the total number of tests per kit as described on the package insert.
Source facts
- Action
- Abbott Molecular sent a Field Advisory Notice letter to all RealTime HIV-1, CT/NG and HBV assay customers on December 20, 2010, informing them that internal testing identified the potential of under filled and over filled enzyme vials which may result in obtaining less than the total number of tests per kit as described in the package insert. The customers were told that specimens that meet acceptance criteria, per the product labeling are not affected by the situation and are considered valid results, and that the issue has no impact on results for those runs that generate valid results. Any questions were directed to Abbott Technical Support at 1-800-553-7042, Option 2.
- Initiated
- 2010-12-20
- Root cause
- Other
- Terminated
- 2012-11-19
- Distribution
- Nationwide Distribution
- Recall number
- Z-1397-2011
- Recall status
- Terminated
- CDRH record ID
- 96195
- FDA classified
- 2011-02-23
- Recall event number
- 57431